Cargando…
Implementation of a Renal Precision Medicine Program: Clinician Attitudes and Acceptance
A precision health initiative was implemented across a multi-hospital health system, wherein a panel of genetic variants was tested and utilized in the clinical care of chronic kidney disease (CKD) patients. Pharmacogenomic predictors of antihypertensive response and genomic predictors of CKD were p...
Autores principales: | Spiech, Katherine M., Tripathy, Purnima R., Woodcock, Alex M., Sheth, Nehal A., Collins, Kimberly S., Kannegolla, Karthik, Sinha, Arjun D., Sharfuddin, Asif A., Pratt, Victoria M., Khalid, Myda, Hains, David S., Moe, Sharon M., Skaar, Todd C., Moorthi, Ranjani N., Eadon, Michael T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235993/ https://www.ncbi.nlm.nih.gov/pubmed/32224869 http://dx.doi.org/10.3390/life10040032 |
Ejemplares similares
-
Recent Advances in the Non-invasive Diagnosis of Renal Osteodystrophy
por: Moorthi, Ranjani N, et al.
Publicado: (2013) -
Healthcare outcomes in undocumented immigrants undergoing two emergency dialysis approaches
por: Sher, S. Jawad, et al.
Publicado: (2017) -
4438 Twenty-four-hour Urinary Sodium Excretion Estimated from a Spot Urine Sample May Be Used as an Indicator of Intake in CKD Patients
por: Lobene, Andrea, et al.
Publicado: (2020) -
Nephrotoxicity in a Patient With Inadequate Pain Control: Potential Role of Pharmacogenetic Testing for Cytochrome P450 2D6 and Apolipoprotein L1
por: Tillman, Emma M., et al.
Publicado: (2020) -
A randomized phase 1b cross-over study of the safety of low-dose pioglitazone for treatment of autosomal dominant polycystic kidney disease
por: Blazer-Yost, Bonnie L, et al.
Publicado: (2021)